Dipyridyl

Dipyridyl

SCHEMBL196501

[Br-].[Br-].[Ni+2].c1ccc(-c2ccccn2)nc1

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Dipyridyl. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.88
LMNA P02545 3/20 0.88
CCR1 P32246 3/20 0.88
CCR5 P51681 3/20 0.88
CCR8 P51685 3/20 0.88
CYP1A2 P05177 1/20 0.88
POLB P06746 1/20 0.88
METAP1 P53582 1/20 0.88
BLM P54132 1/20 0.88
HIF1A Q16665 1/20 0.88
DOHH Q9BU89 1/20 0.88
P4HTM Q9NXG6 1/20 0.88
NPC1 O15118 5/20 0.70
TP53 P04637 4/20 0.70
RAB9A P51151 4/20 0.70
ALOX15 P16050 3/20 0.70
SMN1; SMN2 Q16637 3/20 0.70
L3MBTL1 Q9Y468 3/20 0.70
HTT P42858 2/20 0.70
TDP1 Q9NUW8 2/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dipyridyl SCHEMBL3751791 1.00 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL29768749 1.00 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL2250385 1.00 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL29728717 0.97 KDM4E (0.93) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL230578 0.97 KDM4E (0.93) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL35210403 0.97 KDM4E (0.93) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL30635227 0.97 KDM4E (0.93) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL9644480 0.97 KDM4E (0.93) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL809479 0.94 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8
Dipyridyl SCHEMBL8687972 0.94 KDM4E (0.88) KDM4ELMNACCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0201365-B1 PROCESS FOR THE ELECTROSYNTHESIS OF ALCOHOLS AND EPOXIDE COMPOUNDS SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1989-05-31 EP claimed
US-4637863-A ELECTROCHEMICAL REDUCTION OF ORGANIC HALIDES IN PRESENCE OF CARBONYL DERIVATIVES SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1987-01-20 US claimed
WO-2023245015-A2 PHENYL AMIDE COMPOUNDS AND METHODS OF USE SCHRÖDINGER, INC. (US) 2023-12-21 WO disclosed
CN-114959750-B Method for preparing (E) -2, 2-difluoro-4-phenylbut-3-ethyl enoate compound by electrocatalytic 上海第二工业大学 2023-09-01 CN disclosed
CN-114959750-B Method for preparing (E) -2, 2-difluoro-4-phenylbut-3-ethyl enoate compound by electrocatalytic 上海第二工业大学 2023-09-01 CN disclosed
CN-114959750-A Method for preparing (E) -2, 2-difluoro-4-phenylbutan-3-ethyl enoate compound through electrocatalysis 上海第二工业大学 2022-08-30 CN disclosed
US-9624209-B2 Substituted phenylureas and phenylamides as vanilloid receptor ligands GRUENENTHAL GMBH (DE) 2017-04-18 US disclosed
US-20150099728-A1 Substituted Phenylureas and Phenylamides as Vanilloid Receptor Ligands MEDIFRON DBT INC. (KR) 2015-04-09 US disclosed
US-8946204-B2 Substituted phenylureas and phenylamides as vanilloid receptor ligands GRUENENTHAL GMBH (DE) 2015-02-03 US disclosed
US-8937092-B2 Aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands GRUENENTHAL GMBH (DE) 2015-01-20 US disclosed
US-8791268-B2 Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions GRUENENTHAL GMBH (DE) 2014-07-29 US disclosed
EP-1465277-A1 Solid polymer electrolyte and protonconducting membrane HONDA MOTOR CO., Ltd. (JP) 2004-10-06 EP disclosed
US-20020172850-A1 Polymer electrolyte membrane and solid polymer electrolyte fuel cell using same HONDA GIKEN KOGYO KABUSHIKI KAISHA, JSR CORPORATION 2002-11-21 US disclosed
US-6426396-B2 PARAPHENYLENE POLYMER PRODUCED BY REMOVING THE SUBSTITIUENTS FROM THE CYCLOHEXADIENE RING; NICKEL BASED CATALYST; ELECTROCONDUCTIVITY KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2002-07-30 US disclosed
US-20020007026-A1 POLY (CYCLIC CONJUGATED DIENE) AND PROCESS FOR PRODUCING THE SAME NAKANO MITSURU (JP) 2002-01-17 US disclosed
EP-0956312-B1 PROCESS FOR PRODUCING PHENYLENE-CONTAINING POLYMER AND FILM-FORMING MATERIAL JSR CORP (JP) 2001-10-10 EP disclosed
US-6300465-B1 Process for producing phenylene-containing polymer and film-forming material JSR CORPORATION (JP) 2001-10-09 US disclosed
EP-0956312-A1 PROCESS FOR PRODUCING PHENYLENE-CONTAINING POLYMER AND FILM-FORMING MATERIAL JSR Corporation (JP) 1999-11-17 EP disclosed
WO-1998033836-A1 PROCESS FOR PRODUCING PHENYLENE-CONTAINING POLYMER AND FILM-FORMING MATERIAL JSR CORPORATION (JP) 1998-08-06 WO disclosed
US-4637863-A ELECTROCHEMICAL REDUCTION OF ORGANIC HALIDES IN PRESENCE OF CARBONYL DERIVATIVES SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1987-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099728-A1 Substituted Phenylureas and Phenylamides as Vanilloid Receptor Ligands TRPV1, TRPV5, TRPV6 KDM4E 2471/4885LMNA 3395/4885CCR1 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.